🎉 M&A multiples are live!
Check it out!

AnteoTech Valuation Multiples

Discover revenue and EBITDA valuation multiples for AnteoTech and similar public comparables like Perspective Therapeutics, InfuSystem, and SmartVest.

AnteoTech Overview

About AnteoTech

AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its key areas are the Energy and Life Science Division. The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the AnteoTech IP.


Founded

1995

HQ

Australia
Employees

40

Website

anteotech.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$20.7M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

AnteoTech Financials

AnteoTech has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, AnteoTech achieved revenue of $0.3M and an EBITDA of -$7.4M.

AnteoTech expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See AnteoTech valuation multiples based on analyst estimates

AnteoTech P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $0.2M $0.3M XXX XXX XXX
Gross Profit $0.5M $0.2M XXX XXX XXX
Gross Margin 208% 79% XXX XXX XXX
EBITDA -$7.8M -$7.4M XXX XXX XXX
EBITDA Margin -3378% -2547% XXX XXX XXX
Net Profit -$6.8M -$8.0M XXX XXX XXX
Net Margin -2930% -2749% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

AnteoTech Stock Performance

As of March 17, 2025, AnteoTech's stock price is AUD 0 (or $0).

AnteoTech has current market cap of AUD 37.9M (or $24.0M), and EV of AUD 32.8M (or $20.7M).

See AnteoTech trading valuation data

AnteoTech Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$20.7M $24.0M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

AnteoTech Valuation Multiples

As of March 17, 2025, AnteoTech has market cap of $24.0M and EV of $20.7M.

AnteoTech's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate AnteoTech's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for AnteoTech and 10K+ public comps

AnteoTech Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $20.7M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA n/a XXX XXX XXX
P/E n/a XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get AnteoTech Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

AnteoTech Valuation Multiples

AnteoTech's NTM/LTM revenue growth is n/a

AnteoTech's revenue per employee for the last fiscal year averaged $7K, while opex per employee averaged $0.2M for the same period.

Over next 12 months, AnteoTech's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate AnteoTech's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for AnteoTech and other 10K+ public comps

AnteoTech Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 26% XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth -5% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $7K XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue 132% XXX XXX XXX XXX
G&A Expenses to Revenue 1153% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 2873% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

AnteoTech Public Comps

See public comps and valuation multiples for Medical Devices and Pharma Diagnostics & Analytics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

AnteoTech M&A and Investment Activity

AnteoTech acquired  XXX companies to date.

Last acquisition by AnteoTech was  XXXXXXXX, XXXXX XXXXX XXXXXX . AnteoTech acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by AnteoTech

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About AnteoTech

When was AnteoTech founded? AnteoTech was founded in 1995.
Where is AnteoTech headquartered? AnteoTech is headquartered in Australia.
How many employees does AnteoTech have? As of today, AnteoTech has 40 employees.
Is AnteoTech publicy listed? Yes, AnteoTech is a public company listed on ASX.
What is the stock symbol of AnteoTech? AnteoTech trades under ADO ticker.
When did AnteoTech go public? AnteoTech went public in 2000.
Who are competitors of AnteoTech? Similar companies to AnteoTech include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of AnteoTech? AnteoTech's current market cap is $24.0M
What is the current revenue growth of AnteoTech? AnteoTech revenue growth between 2023 and 2024 was 26%.
Is AnteoTech profitable? Yes, AnteoTech is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.